Phospholipid membrane surface

Phospholipid membrane surfaces are the primary structural elements of biological membranes, composed of a bilayer of amphiphilic lipids that define cellular and organelle boundaries (Molecular Biology of the Cell, 4th ed.). These surfaces are not merely passive barriers; they provide a dynamic environment for protein-lipid interactions, signal transduction, and the regulation of molecular transport. In a therapeutic context, the phospholipid bilayer is a critical target for several classes of antibiotics and antifungals that exploit differences in membrane composition, such as charge and sterol content, between pathogens and host cells. For example, daptomycin targets the bacterial cytoplasmic membrane to cause rapid depolarization, while polymyxins interact with the anionic phospholipids of Gram-negative bacteria. However, because phospholipid structures are ubiquitous in human biology, drugs targeting these surfaces often face significant safety challenges, including nephrotoxicity and hemolysis, necessitating careful dosing and monitoring. Recent research also explores the role of membrane lipid composition in cancer cell resistance and neurodegenerative protein aggregation, suggesting broader therapeutic implications for membrane-active agents.

Other names

Lipid bilayerCell membrane surfacePlasma membraneBiological membranePhospholipid bilayer

Drugs targeting phospholipid membrane surfaces typically act through physical disruption, such as pore formation, membrane thinning, or depolarization of the transmembrane potential. For instance, lipopeptides like daptomycin insert into the membrane in a calcium-dependent manner to cause ion leakage (StatPearls, 2023), while polyene antifungals like Amphotericin B bind to membrane sterols to create aqueous pores, leading to cell death (PubChem, CID 5280965). Polymyxins act as detergents, binding to anionic phospholipids and lipopolysaccharides to disrupt the integrity of the Gram-negative bacterial outer and inner membranes (PubMed, PMID: 30634408).